492 related articles for article (PubMed ID: 27449263)
1. Phase II Evaluation of Magnetic Resonance Imaging Guided Focal Laser Ablation of Prostate Cancer.
Eggener SE; Yousuf A; Watson S; Wang S; Oto A
J Urol; 2016 Dec; 196(6):1670-1675. PubMed ID: 27449263
[TBL] [Abstract][Full Text] [Related]
2. Focal Laser Ablation of Prostate Cancer: Feasibility of Magnetic Resonance Imaging-Ultrasound Fusion for Guidance.
Natarajan S; Jones TA; Priester AM; Geoghegan R; Lieu P; Delfin M; Felker E; Margolis DJA; Sisk A; Pantuck A; Grundfest W; Marks LS
J Urol; 2017 Oct; 198(4):839-847. PubMed ID: 28396184
[TBL] [Abstract][Full Text] [Related]
3. MR imaging-guided focal laser ablation for prostate cancer: phase I trial.
Oto A; Sethi I; Karczmar G; McNichols R; Ivancevic MK; Stadler WM; Watson S; Eggener S
Radiology; 2013 Jun; 267(3):932-40. PubMed ID: 23440319
[TBL] [Abstract][Full Text] [Related]
4. Focal Laser Ablation of Prostate Cancer: Phase I Clinical Trial.
Natarajan S; Raman S; Priester AM; Garritano J; Margolis DJ; Lieu P; Macairan ML; Huang J; Grundfest W; Marks LS
J Urol; 2016 Jul; 196(1):68-75. PubMed ID: 26748164
[TBL] [Abstract][Full Text] [Related]
5. Magnetic resonance image-guided focal laser ablation in clinically localized prostate cancer: safety and efficacy.
Al-Hakeem Y; Raz O; Gacs Z; Maclean F; Varol C
ANZ J Surg; 2019 Dec; 89(12):1610-1614. PubMed ID: 31679182
[TBL] [Abstract][Full Text] [Related]
6. Two-year Outcomes Following Focal Laser Ablation of Localized Prostate Cancer.
Chao B; Llukani E; Lepor H
Eur Urol Oncol; 2018 Jun; 1(2):129-133. PubMed ID: 31100236
[TBL] [Abstract][Full Text] [Related]
7. MRI Findings After MRI-Guided Focal Laser Ablation of Prostate Cancer.
Westin C; Chatterjee A; Ku E; Yousuf A; Wang S; Thomas S; Fan X; Eggener S; Karczmar G; Oto A
AJR Am J Roentgenol; 2018 Sep; 211(3):595-604. PubMed ID: 29995499
[TBL] [Abstract][Full Text] [Related]
8. Gold nanoshell-localized photothermal ablation of prostate tumors in a clinical pilot device study.
Rastinehad AR; Anastos H; Wajswol E; Winoker JS; Sfakianos JP; Doppalapudi SK; Carrick MR; Knauer CJ; Taouli B; Lewis SC; Tewari AK; Schwartz JA; Canfield SE; George AK; West JL; Halas NJ
Proc Natl Acad Sci U S A; 2019 Sep; 116(37):18590-18596. PubMed ID: 31451630
[TBL] [Abstract][Full Text] [Related]
9. Focal Therapy for Prostate Cancer with In-Bore MR-guided Focused Ultrasound: Two-Year Follow-up of a Phase I Trial-Complications and Functional Outcomes.
Tay KJ; Cheng CWS; Lau WKO; Khoo J; Thng CH; Kwek JW
Radiology; 2017 Nov; 285(2):620-628. PubMed ID: 28654336
[TBL] [Abstract][Full Text] [Related]
10. Complications, Recovery, and Early Functional Outcomes and Oncologic Control Following In-bore Focal Laser Ablation of Prostate Cancer.
Lepor H; Llukani E; Sperling D; Fütterer JJ
Eur Urol; 2015 Dec; 68(6):924-6. PubMed ID: 25979568
[TBL] [Abstract][Full Text] [Related]
11. Magnetic resonance guided focused high frequency ultrasound ablation for focal therapy in prostate cancer - phase 1 trial.
Ghai S; Perlis N; Lindner U; Hlasny E; Haider MA; Finelli A; Zlotta AR; Kulkarni GS; van der Kwast TH; McCluskey SA; Kucharczyk W; Trachtenberg J
Eur Radiol; 2018 Oct; 28(10):4281-4287. PubMed ID: 29696431
[TBL] [Abstract][Full Text] [Related]
12. Focal Laser Ablation of Prostate Cancer: Results in 120 Patients with Low- to Intermediate-Risk Disease.
Walser E; Nance A; Ynalvez L; Yong S; Aoughsten JS; Eyzaguirre EJ; Williams SB
J Vasc Interv Radiol; 2019 Mar; 30(3):401-409.e2. PubMed ID: 30819483
[TBL] [Abstract][Full Text] [Related]
13. Magnetic Resonance Imaging-Guided Transurethral Ultrasound Ablation of Prostate Tissue in Patients with Localized Prostate Cancer: A Prospective Phase 1 Clinical Trial.
Chin JL; Billia M; Relle J; Roethke MC; Popeneciu IV; Kuru TH; Hatiboglu G; Mueller-Wolf MB; Motsch J; Romagnoli C; Kassam Z; Harle CC; Hafron J; Nandalur KR; Chronik BA; Burtnyk M; Schlemmer HP; Pahernik S
Eur Urol; 2016 Sep; 70(3):447-55. PubMed ID: 26777228
[TBL] [Abstract][Full Text] [Related]
14. Prospective Multicenter Phase II Study on Focal Therapy (Hemiablation) of the Prostate with High Intensity Focused Ultrasound.
Ganzer R; Hadaschik B; Pahernik S; Koch D; Baumunk D; Kuru T; Heidenreich A; Stolzenburg JU; Schostak M; Blana A
J Urol; 2018 Apr; 199(4):983-989. PubMed ID: 29107031
[TBL] [Abstract][Full Text] [Related]
15. Real-Time MRI-Guided Focused Ultrasound for Focal Therapy of Locally Confined Low-Risk Prostate Cancer: Feasibility and Preliminary Outcomes.
Ghai S; Louis AS; Van Vliet M; Lindner U; Haider MA; Hlasny E; Spensieri P; Van Der Kwast TH; McCluskey SA; Kucharczyk W; Trachtenberg J
AJR Am J Roentgenol; 2015 Aug; 205(2):W177-84. PubMed ID: 26204305
[TBL] [Abstract][Full Text] [Related]
16. Comparative analysis of transperineal template saturation prostate biopsy versus magnetic resonance imaging targeted biopsy with magnetic resonance imaging-ultrasound fusion guidance.
Radtke JP; Kuru TH; Boxler S; Alt CD; Popeneciu IV; Huettenbrink C; Klein T; Steinemann S; Bergstraesser C; Roethke M; Roth W; Schlemmer HP; Hohenfellner M; Hadaschik BA
J Urol; 2015 Jan; 193(1):87-94. PubMed ID: 25079939
[TBL] [Abstract][Full Text] [Related]
17. Hemigland Cryoablation of Clinically Significant Prostate Cancer: Intermediate-Term Followup via Magnetic Resonance Imaging Guided Biopsy.
Chuang R; Kinnaird A; Kwan L; Sisk A; Barsa D; Felker E; Delfin M; Marks L
J Urol; 2020 Nov; 204(5):941-949. PubMed ID: 32985924
[TBL] [Abstract][Full Text] [Related]
18. Prostate cancer treatment by the latest focal HIFU device with MRI/TRUS-fusion control biopsies: A prospective evaluation.
von Hardenberg J; Westhoff N; Baumunk D; Hausmann D; Martini T; Marx A; Porubsky S; Schostak M; Michel MS; Ritter M
Urol Oncol; 2018 Sep; 36(9):401.e1-401.e9. PubMed ID: 30093211
[TBL] [Abstract][Full Text] [Related]
19. Extensive Histological Sampling following Focal Therapy of Clinically Significant Prostate Cancer with High Intensity Focused Ultrasound.
Mortezavi A; Krauter J; Gu A; Sonderer J; Bruhin J; Reeve KA; Held L; Donati OF; Rupp NJ; Moch H; Sulser T; Eberli D
J Urol; 2019 Oct; 202(4):717-724. PubMed ID: 31042109
[TBL] [Abstract][Full Text] [Related]
20. Focal cryoablation: a treatment option for unilateral low-risk prostate cancer.
Durand M; Barret E; Galiano M; Rozet F; Sanchez-Salas R; Ahallal Y; Macek P; Gaya JM; Cerruti J; Devilliers H; Loeffler J; Amiel J; Vallancien G; Cathelineau X
BJU Int; 2014 Jan; 113(1):56-64. PubMed ID: 24053685
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]